These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6995288)

  • 61. Tissue distribution of CysAP activity and its relationship to blood pressure and water balance.
    Prieto I; Villarejo AB; Segarra AB; Wangensteen R; Banegas I; de Gasparo M; Vanderheyden P; Zorad S; Vives F; Ramírez-Sánchez M
    Life Sci; 2015 Aug; 134():73-8. PubMed ID: 26006037
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analogs of phosphatidylcholine: alpha-adrenergic antagonists from the renal medulla.
    Smith KA; Prewitt RL; Byers LW; Muirhead EE
    Hypertension; 1981; 3(4):460-70. PubMed ID: 6118327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiovascular hypertrophy in hypertension. Arthur C. Corcoran Memorial Lecture.
    Tarazi RC
    Hypertension; 1986 Jun; 8(6 Pt 2):II187-90. PubMed ID: 3013769
    [No Abstract]   [Full Text] [Related]  

  • 64. [Study of the mechanism of action of a vasodepressor lipid of renal origin and its relation to the antihypertensive function of the kidneys].
    Somova LI
    Patol Fiziol Eksp Ter; 1973; 17(1):17-22. PubMed ID: 4755538
    [No Abstract]   [Full Text] [Related]  

  • 65. [Kidney medulla and hypertension, with special reference to antihypertensive lipids].
    Masugi F; Hagiwara T; Kumahara Y
    Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):846-7. PubMed ID: 6663856
    [No Abstract]   [Full Text] [Related]  

  • 66. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
    Castro-Moreno P; Pardo JP; Hernández-Muñoz R; López-Guerrero JJ; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M; Villalobos-Molina R
    Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):61-9. PubMed ID: 22994939
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chronic hypotensive effects of verapamil in angiotensin hypertension are steroid independent.
    Lohmeier TE; Montani JP; Smith MJ; Rushing EL
    Hypertension; 1989 Mar; 13(3):273-82. PubMed ID: 2921081
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanisms underlying the antihypertensive functions of the renal medulla.
    Bergström G; Evans RG
    Acta Physiol Scand; 2004 Aug; 181(4):475-86. PubMed ID: 15283761
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effects of puerarin on blood pressure, blood lipid and renal structure of cold-induced hypertensive mice].
    Pan ZJ; Yan GL; Wang LP; Xu XX; Pan L
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Nov; 27(4):436-8. PubMed ID: 22295519
    [No Abstract]   [Full Text] [Related]  

  • 70. [The effect of benzonal and benzamyl on renal function in dogs with experimental hypertension].
    Pashinskiĭ VG
    Farmakol Toksikol; 1967; 30(1):71-4. PubMed ID: 5594363
    [No Abstract]   [Full Text] [Related]  

  • 71. Chemical renal medullectomy. Effect on urinary prostaglandin E2 and plasma renin in response to variations in sodium intake and in relation to blood pressure.
    Bing RF; Russell GI; Thurston H; Swales JD; Godfrey N; Lazarus Y; Jackson J
    Hypertension; 1983; 5(6):951-7. PubMed ID: 6360871
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Renomedullary deficiency. A contributory factor in the pathogenesis of experimental renal hypertension.
    Susic D; Sparks JC; Machado EA
    Experientia; 1976 Mar; 32(3):354-5. PubMed ID: 1253908
    [No Abstract]   [Full Text] [Related]  

  • 73. [The osmoregulating function of the kidney and activity of the loop of Henle in water rats, gerbils and Brattleboro rats].
    Natochin IuV; Dlouha H; Lavrova EA; Pechurkina NI; Podsekaeva NI
    Fiziol Zh SSSR Im I M Sechenova; 1983 May; 69(5):695-700. PubMed ID: 6873378
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH; Venema RC; Pollock DM
    Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An alternate road.
    Muirhead EE
    Blood Press; 1992 Oct; 1(3):132-4. PubMed ID: 1345044
    [No Abstract]   [Full Text] [Related]  

  • 76. Muirhead's syndrome--a syndrome of medullipin dependent hypotension.
    Hansson L; Hedner T; Jern S
    Blood Press; 1992 Oct; 1(3):131. PubMed ID: 1345043
    [No Abstract]   [Full Text] [Related]  

  • 77. Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.
    Damiani E; Ullrich SE
    Prog Lipid Res; 2016 Jul; 63():14-27. PubMed ID: 27073146
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lipid acetylation reactions and the metabolism of platelet-activating factor.
    Baker RR
    Neurochem Res; 2000 May; 25(5):677-83. PubMed ID: 10905630
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Muirhead's syndrome and medullipin. A new syndrome and a unique hypotensive agent.
    Swales JD
    Br Heart J; 1993 Sep; 70(3):211. PubMed ID: 8398487
    [No Abstract]   [Full Text] [Related]  

  • 80. Blood pressure and the kidney.
    Swales JD
    J Clin Pathol; 1981 Nov; 34(11):1233-40. PubMed ID: 7033298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.